US Edition
Innocan Pharma Reports First Half Of 2025 Financial Results
Summary by Mg Magazine – Cannabis News & Information
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Innocan Pharma Reports First Half Of 2025 Financial Results
HERZLIYA, Israel, and CALGARY, AB — Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing drug delivery platform technologies, reported its financial consolidated results for the six months ended June 30, 2025. First Half Of 2025 Financial Highlights Revenues decreased 4% in the first half of 2025 to US$14.8M, compared to US$15.4M in the first half of 2024. The revenue decline was attributed to the uncertainty an…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
